Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic spleen aminopeptide oral solution for seasonal allergic rhinitis in Hohhot (2025 extension)
ChiCTR2500104461Phase 4Not yet recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of spleen polypeptide in allergic rhinitis (AR), sponsored by Beijing Shijitan Hospital. Primary endpoints: Symptom score (four-point method), Symptom score (VAS visual analog scale) and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
spleen polypeptide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2500104461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104461.